Education
About Us
Working with TipRanks
Follow Us
Chordia Therapeutics Inc. (JP:190A)
:190A
190A Stock Chart & Stats
¥106.00
-¥9.00(-2.81%)
At close: 4:00 PM EST
¥106.00
-¥9.00(-2.81%)
Day’s Range― - ―
52-Week Range¥98.00 - ¥457.00
Previous CloseN/A
Volume2.20M
Average Volume (3M)565.44K
Market Cap
¥7.09B
Enterprise Value¥9.87B
Total Cash (Recent Filing)¥2.82B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Jan 20, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.60
Shares Outstanding70,180,100
10 Day Avg. Volume542,310
30 Day Avg. Volume565,443
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)5.07
Price to Sales (P/S)0.00
P/FCF Ratio-6.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Chordia Therapeutics Inc. News
190A FAQ
What was Chordia Therapeutics Inc.’s price range in the past 12 months?
Chordia Therapeutics Inc. lowest stock price was ¥98.00 and its highest was ¥457.00 in the past 12 months.
What is Chordia Therapeutics Inc.’s market cap?
Chordia Therapeutics Inc.’s market cap is ¥7.09B.
When is Chordia Therapeutics Inc.’s upcoming earnings report date?
Chordia Therapeutics Inc.’s upcoming earnings report date is Jan 20, 2026 which is in 36 days.
How were Chordia Therapeutics Inc.’s earnings last quarter?
Chordia Therapeutics Inc. released its earnings results on Oct 10, 2025. The company reported -¥5.6 earnings per share for the quarter, missing the consensus estimate of N/A by -¥5.6.
Is Chordia Therapeutics Inc. overvalued?
According to Wall Street analysts Chordia Therapeutics Inc.’s price is currently Overvalued.
Does Chordia Therapeutics Inc. pay dividends?
Chordia Therapeutics Inc. does not currently pay dividends.
What is Chordia Therapeutics Inc.’s EPS estimate?
Chordia Therapeutics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chordia Therapeutics Inc. have?
Chordia Therapeutics Inc. has 70,180,100 shares outstanding.
What happened to Chordia Therapeutics Inc.’s price movement after its last earnings report?
Chordia Therapeutics Inc. reported an EPS of -¥5.6 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.542%.
Which hedge fund is a major shareholder of Chordia Therapeutics Inc.?
Currently, no hedge funds are holding shares in JP:190A
Company Description
Chordia Therapeutics Inc.
Chordia Therapeutics Inc. (190A) is a biopharmaceutical company engaged in the research, development, and commercialization of innovative therapies for oncology patients. The company focuses on discovering and developing small-molecule drugs targeting cancer-related pathways, aiming to provide effective treatment options for various types of cancer. Chordia Therapeutics is committed to advancing its pipeline of proprietary therapeutic candidates through clinical trials to address unmet medical needs in the oncology sector.
Technical Analysis
Nihon Chouzai Co
―
Pharmarise Holdings Corp.
―
Medical System Network Co., Ltd.
―
Tsubota Laboratory Incorporated
―
Astena Holdings Co.,Ltd.
―